Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience

Ekaterina A Dobreva1, Anna M Gorbacheva1, Ekaterina E Bibik1

  • 1Department of Parathyroid Glands Pathology, Endocrinology Research Centre, Moscow, Russia.

PubMed

Insights

Primary hyperparathyroidism (PHPT) is linked to cardiovascular diseases (CVD) and metabolic disorders (MD). Older PHPT patients show higher rates of obesity, type 2 diabetes, and hypertension, indicating increased CVD risk with age.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Medicine

Background:

  • Cardiovascular diseases (CVD) and metabolic disorders (MD) are leading causes of morbidity and mortality.
  • Primary hyperparathyroidism (PHPT) is increasingly recognized as a condition associated with a higher incidence of CVD and MD.

Purpose of the Study:

  • To determine the prevalence and types of CVD and MD in hospitalized patients with PHPT.
  • To investigate potential associations between PHPT and these comorbidities.

Main Methods:

  • Analysis of 838 hospitalized patients with verified PHPT.
  • Cohort divided into two age groups: 18-49 years (Group A) and 50+ years (Group B).

Main Results:

  • Older patients (Group B) exhibited higher rates of obesity (35.9% vs. 24.2%), type 2 diabetes mellitus (14.4% vs. 2.6%), arterial hypertension (79.1%), ischemic heart disease (10.8%), chronic heart failure (8.4%), and brachiocephalic artery atherosclerosis (84%).
  • Risk factors for CVD detection included age over 56 years, eGFR below 92 ml/min/1.73m², and BMI above 28.3 kg/m².

Conclusions:

  • PHPT is associated with a high incidence of cardiovascular diseases and metabolic disorders.
  • Age is a significant factor influencing the prevalence of these comorbidities in PHPT patients.
Abstract

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
2.2K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16